Abstract
Background
Good medication labeling practices are imperative to ensure safe medication use. Non-adherence to labeling protocols is reported as one major source of medication errors.
Objective
This study was intended to evaluate and compare adherence to labeling guidelines for dispensed medications among the hospitals of the five different health sectors in the city of Riyadh, Saudi Arabia.
Methods
A descriptive, cross-sectional analysis was conducted among 14 public hospitals in the city of Riyadh, Saudi Arabia. Labeling guidelines issued by the Institute for Safe Medication Practices were used as a standard assessment tool. A total of 218 medication labels were collected and evaluated for labeling adequacy. Descriptive statistics were used to elaborate the study findings. All analyses were performed with Microsoft Access.
Results
The study showed a substantial rate of adherence to the labeling guidelines. In terms of the established criteria, community and mail orders were reported to adhere strongly (90.5%), whereas injectables adhered least to the labeling guidelines. The labeling format, contents of the label, instructions on the labels, abbreviations used on the labels and drug names were also consistent with the guidelines (80.0%, 84.0%, 88.0%, 97.7% and 85.5%, respectively). Organizations belonging to the public sector reported a higher level of adherence (⩾80.0%) than the level found for private hospitals (70.0%).
Conclusion
In Riyadh hospitals, medication labeling following the guidelines issued by the Institute for Safe Medication Practices, is well accepted and rationally practiced. However, a nationwide study is recommended to evaluate if the guidelines are followed throughout Saudi Arabia.
Keywords: Medication labeling guidelines, Saudi Arabia
1. Introduction
The labeling of medications encompasses the provision of information and instructions to ensure the safe and effective use of the products by patients. The labels of dispensed medications represent one of the most important sources of information available to patients (Neoh et al., 2009). Legitimately, labeling information includes but is not limited to the following categories: patient identification, medication name, dosage, frequency, route of administration, production and expiration date and some medication storage requirements (Brown-Brumfield and Deleon, 2010). In contrast, medication labeling in actual practice is almost always inconsistent, incomplete or difficult for patients to understand (Shrank et al., 2007; Orser, 2000). This vague information causes medication errors and produces very large economic and societal losses (Aspden, 2007; Bootman et al., 2006).
Within this context, The Joint Commission, an organization that accredits health care organizations in the United States, described communication error as the cause of 60–70% of preventable hospital deaths (Murphy and Dunn, 2010). Despite the ongoing efforts by international safety organizations (JCAHO, 2007), medication errors associated with labeling and packaging are frequently reported (Cohen, 2007). Therefore, based on the scrutiny of actual medication errors reported and a review of pharmacy-generated labels produced by a number of systems, the Institute for Safe Medication Practices (ISMP), an organization that educates the health care community and consumers about safe medication practices, released its “Designing a medication label for use in the acute care and community pharmacy settings” guidelines in 2010 (ISMP, 2010). These guidelines provide detailed information on labeling requirements for oral liquid, oral solid, injectables, intravenous piggyback, and community and mail-order pharmacy prescription packages (ISMP, 2010). The aim of these guidelines is to promote rational labeling standards, thus preventing medication errors. However, The Joint Commission, The Joint Commission International and ISMP are organizations in the United States and complying with their guidelines is voluntary.
Concern may also focus on labeling practices in Saudi Arabia, but less is known about this issue. To the best of our knowledge and judging from the results of an extensive literature review, adherence to ISMP labeling guidelines has not yet been investigated in Saudi Arabia. For this reason, there are inadequate data on the impact of current labeling practices on health professionals and use of medications by patients. Furthermore, compliance with labeling guidelines has not been compared among different health care sectors. A pilot study was conducted in an effort to expand our current knowledge on compliance by health care professionals with the current labeling guidelines. The study aimed to evaluate adherence to ISMP labeling guidelines and to compare the level of adherence among different health care sectors in the city of Riyadh, Kingdom of Saudi Arabia.
2. Methods
The study was designed as a cross-sectional comparative analysis. The study was conducted in Riyadh, the capital of Saudi Arabia. The total number of hospitals in Riyadh is forty-five as per the 2012, Ministry of Health in Saudi Arabia census. From these hospitals, fourteen (30% of the total number of hospitals) from five different health sectors (Ministry of Health Sector, Military Sector, Referral Sector, Teaching Hospitals Sector and Private Sector) were targeted for data collection. Approval to conduct the study was obtained from the Medication Safety Research Chair Research Committee at King Saud University. No patient-related information was collected to maintain confidentiality.
The ISMP guidelines for medication label design were used to design a data collection tool. The guidelines were divided into five major sections (label format, label content, label explicit instructions, drug name and abbreviation section). Five different types of labels were included in the study: community and mail order, intravenous piggyback, oral liquids, oral solids and injectable syringes. The first drafts of the collection tool were reviewed by an ISMP representative. Few modifications were needed, and the representative’s comments and guidelines were considered in finalizing the data collection checklists.
A suitable sampling technique was used for data collection. This established technique was to retrieve at least one label of each category from each individual hospital. The sampling distribution is shown in (Table 1). The study was conducted from October 2010 to December 10, 2010. A total of 208 medication labels were collected. The data were entered and summarized with Microsoft Access.
Table 1.
Number of labels per hospital.
| Label type |
Hospitals |
Total | ||||
|---|---|---|---|---|---|---|
| MOH⁎ (N = 5) | Military (N = 2) | Referral (N = 5) | Teaching (N = 4) | Private (N = 4) | ||
| Community and mail orders | 6 | 8 | 24 | 15 | 10 | 63 |
| Oral solids | 4 | 6 | 20 | 12 | 4 | 46 |
| Oral liquids | 3 | 1 | 19 | 9 | 1 | 33 |
| Injectables | 4 | 2 | 13 | 13 | 1 | 33 |
| Intravenous Piggyback | 3 | 6 | 8 | 7 | 9 | 33 |
| Total | 20 | 23 | 84 | 56 | 25 | 208 |
Ministry of Health.
3. Results
Two hundred and eight labels were collected from 14 hospitals, as shown in Table 1. The majority of the labels were collected from referral hospitals (n = 84, 44.0%), followed by teaching hospitals (n = 56, 27%), private hospitals (n = 25, 12%), military services hospitals (n = 23, 11%) and Ministry of Health (MOH) hospitals (n = 20, 10%).
3.1. Adherence rates
The overall adherence rates to the guidelines for community and mail order, oral solids, intravenous piggyback, oral liquid and injectable medication labels were 90.5%, 88.0%, 85.8%, 83.74%, and 81.0%, respectively. In addition, the rates of adherence to the label format, contents, instructions, abbreviation, and drug name sections were 80.0%, 84.0%, 88.0%, 97.7%, and 85.8%, respectively, as shown in (Table 2).
Table 2.
ISMP label adherence rates.
| Label | Label format (%) | Label contents (%) | Explicit instruction (%) | Abbreviations (%) | Drug name (%) | Total adherence (%) |
|---|---|---|---|---|---|---|
| Injectables | 79.0 | 72.2 | NA | 96.4 | 76.4 | 81.0 |
| Oral solids | 77.1 | 86.8 | 90.2 | 98.5 | 87.25 | 88.0 |
| Oral Liquids | 79.3 | 83.6 | 84.7 | 98.6 | 72.5 | 83.7 |
| Community and mail orders | 87.6 | 92.5 | 92.2 | 99.6 | 80.7 | 90.5 |
| Intravenous piggyback | 76.5 | 88.0 | 84.7 | 95.8 | 84.0 | 85.8 |
NA; Not applicable
Fig. 1 shows the overall level of adherence to all the elements in the guidelines among the five health sectors. Military service hospitals had the highest adherence level (90.1%), followed by MOH hospitals (89.7%), referral (88.2%) and teaching (79.8%). Private hospitals reported the lowest adherence level (70.0%).
Figure 1.

Classification of hospitals in terms of medication label adherence.
The lower adherence levels found in teaching and private hospitals can be explained by the low adherence level shown by these hospitals in the category of explicit instructions on medication labels, as shown in Table 3.
Table 3.
Medication labels and hospitals.
| Hospital & label type | Label format | Label contents | Explicit instructions | Abbreviations | Drug name |
|---|---|---|---|---|---|
| Ministry of Health | |||||
| Intravenous piggyback | 91.6 | 85.7 | 100 | 100 | 79.2 |
| Injectables | 83.0 | 80.0 | NA | 92.5 | 77.4 |
| Oral solids | 91.7 | 93.7 | 100 | 100 | 78.4 |
| Oral liquids | 93.3 | 91.0 | 100 | 100 | 91.0 |
| Community and mail orders | 93.3 | 91.0 | 100 | 100 | 76.0 |
| Total | 90.5 | 88.2 | 100 | 98.5 | 80.4 |
| Military service hospitals | |||||
| Intravenous piggyback | 100 | 95.2 | 94.4 | 100 | 98.0 |
| Injectables | 87.6 | 73.3 | NA | 100 | 85.4 |
| Oral solids | 100 | 90.0 | 100 | 100 | 91.0 |
| Oral liquids | 72.0 | 100 | 100 | 100 | 80.0 |
| Community and mail orders | 72.0 | 82.0 | 100 | 100 | 70.0 |
| Total | 94.4 | 88.1 | 98.6 | 100 | 84.8 |
| Referral hospitals | |||||
| Intravenous piggyback | 87.5 | 89.6 | 86.6 | 97.5 | 85.6 |
| Injectables | 77.8 | 90.0 | NA | 97.0 | 83.0 |
| Oral solids | 73.7 | 88.2 | 100 | 95.5 | 81.0 |
| Oral liquids | 84.0 | 89.0 | 97.4 | 100 | 77.4 |
| Community and mail orders | 82.3 | 89.0 | 97.4 | 100 | 77.4 |
| Total | 81.6 | 89.1 | 95.3 | 98.0 | 80.8 |
| Teaching hospitals | |||||
| Intravenous piggyback | 83.3 | 94.0 | 69.4 | 87.5 | 74.0 |
| Injectables | 90.5 | 83.0 | NA | 95.0 | 84.0 |
| Oral solids | 71.8 | 88.1 | 38.5 | 100 | 75.5 |
| Oral liquids | 76.4 | 84. | 61.1 | 100 | 65.5 |
| Community and mail orders | 80.3 | 87.0 | 61.1 | 100 | 71.1 |
| Total | 80.4 | 87.2 | 57.5 | 96.5 | 74.0 |
| Private hospitals | |||||
| Intravenous piggyback | 87.5 | 89.3 | 83.3 | 100 | 90.6 |
| Injectables | 96.3 | 72.2 | NA | 99.0 | 76.4 |
| Oral solids | 100 | 20.0 | 0.0 | 100 | 72.7 |
| Oral liquids | 77.8 | 23.7 | 50.0 | 100 | 50.0 |
| Community and mail orders | 77.8 | 27.3 | 50.0 | 100 | 50.0 |
| Total | 87.9 | 46.5 | 45.8 | 99.8 | 68.0 |
NA; Not applicable
4. Discussion
Adherence to the label design guidelines for medications used in hospitals is crucial to ensure the safe use of medications. The safety recommendations and initiatives developed by several organizations are related directly or indirectly to the medication labels used in hospitals. For example, The Joint Commission International-Patient Safety Goals emphasizes the use of proper patient identification throughout the process of medication use to avoid the incorrect administration of medication to patients, and this body also emphasizes the use of two patient identifiers (JCIS, 2012). This study showed that the required patient identification available on the medication label complies with the appropriate guidelines for patient identification. In the category of label content, the availability of a second patient identifier varies from 72% for injectable medications to 93% for community and mail-order. The label content for the patient identification section needs to be reviewed for better adherence with the safety requirement.
The proper use of technology throughout the medication use process was shown to possibly improve medication safety and minimize medication errors (Kuiper et al., 2007; Poon et al., 2006). This approach could be pursued and evaluated through the availability of barcodes on medication labels to facilitate barcode scanning of the medication before dispensing and administration. The safe use of medications would be improved significantly by the inclusion of barcode information (Poon et al., 2006). This topic was evaluated under the category of label content, and it represents a potential area for improvement.
In contrast, the hospitals generally showed good adherence to the proper use of medication abbreviations. The adherence rate varied from 96% to 100%. This result indicated no use or a minimal use of dangerous or prohibited abbreviations.
In addition, confusing drug names or “look-alike, sound-alike” medication names are becoming a major safety concern throughout the health care sector worldwide (WHO, 2007). The appropriate display of medication names was evaluated during the survey. This category includes the availability of the generic medication name on the label, the use of an appropriate font and the use of “tall-man” letters if indicated. The adherence rate in this category varied from 72% to 87%. This result indicates that extra effort is needed to ensure the safer display of medication names on the labels. This approach will help to minimize errors resulting from the misinterpretation of medication names by the patients or the health care providers.
Our study has several limitations. Certain hospitals were not willing to share their labels. A smaller sample size resulted from this limitation. In addition, the medications used at several MOH hospitals had no labels, or the labels were available but were not in use.
The current study focused on hospitals and the quality of label information in community pharmacy is unknown. Future studies need to investigate the label information in community pharmacies. In Saudi Arabia, no specific regulations by the Ministry of Health or other authority require certain information to be on the label for medications dispensed by pharmacist in the hospital or community. Having national regulations that ask for minimal medication label information is an essential step to improve the safety of medications dispensed in the hospital or community pharmacy.
In conclusion, this is the first study to investigate hospitals’ adherence to ISMP design guidelines for medication labels in Saudi Arabia. Our results suggest that in terms of the ISMP guidelines, adherence to the medication labeling system is well accepted by the hospitals in Riyadh. Broader studies are needed to ascertain the status of adherence to the ISMP guidelines in the remainder of Saudi Arabia. The national and governmental health care regulatory organizations need to play a strong and leading role in promoting safe medication practices and ensuring the utilization of well-designed medication labels as applicable.
Footnotes
Peer review under responsibility of King Saud University.
References
- Aspden P. National Academies Press; Washington, DC: 2007. Preventing Medication Errors. [Google Scholar]
- Bootman J., Cronenwett L., Bates D. National Academies Press; Washington, DC: 2006. Preventing Medication Errors: Quality Chasm Series. [Google Scholar]
- Brown-Brumfield D., DeLeon A. Adherence to a medication safety protocol: current practice for labeling medications and solutions on the sterile field. AORN. 2010;91(5):610–617. doi: 10.1016/j.aorn.2010.03.002. [DOI] [PubMed] [Google Scholar]
- Cohen M.R. American Pharmacist Association; Washington, DC: 2007. Medication Errors. [Google Scholar]
- Institute for Safe Medication Practices. Principles of designing a medication label for community and mail order pharmacy prescription packages. 2010 [April 29, 2012]; Available from: <http://www.ismp.org/tools/guidelines/labelFormats/comments/printerVersion.pdf>.
- Joint Commission International Standards. Accessed October 10, 2012. Available from: <www.jointcommissioninternational.org/.../standards_only-hosp_3rd_ed.pdf>.
- Joint Commission on Accreditation of Healthcare Organizations, Joint Commission Resources Inc . Joint Commission Resources; Illinois: 2006. Meeting the Joint Commission’s 2007 National-Patient Safety Goals. [Google Scholar]
- Kuiper S.A., McCreadie S.R., Mitxhell J.F., Stevenson J.G. Medication errors in inpatient pharmacy operation and technologies for improvement. American Journal of Health-System Pharmacy. 2007;64(9):955–959. doi: 10.2146/ajhp060267. [DOI] [PubMed] [Google Scholar]
- Murphy J.G., Dunn W.F. Medical errors and poor communication. Chest. 2010;138(6):1292–1293. doi: 10.1378/chest.10-2263. [DOI] [PubMed] [Google Scholar]
- Neoh C.F., Hassali M.A., Shafie A.A., Awaisu A., Tambyappa J. Compliance towards dispensed medication labelling standards: a cross-sectional study in the state of Penang. Malaysia Current Drug Safety. 2009;4(3):199–203. doi: 10.2174/157488609789006921. [DOI] [PubMed] [Google Scholar]
- Orser B. Reducing medication errors. Canadian Medical Association Journal. 2000;162(8):1150–1151. [PMC free article] [PubMed] [Google Scholar]
- Poon E.G., Cina J.L., Churchill W., Patel N., Featherstone E., Rothschild J.M., Keohane C.A. Medication Dispensing Errors and Potential Adverse Drug Events before and after implementing bar Code Technology in the Pharmacy. Annals of Internal Medicine. 2006;145(6):426–434. doi: 10.7326/0003-4819-145-6-200609190-00006. [DOI] [PubMed] [Google Scholar]
- Shrank W.H., Agnew-Blais J., Choudhry N.K., Wolf M.S., Kesselheim A.S., Avorn J. The variability and quality of medication container labels. Archives of Internal Medicine. 2007;167(16):1760–1765. doi: 10.1001/archinte.167.16.1760. [DOI] [PubMed] [Google Scholar]
- WHO Collaborating Center for Patient Safety Solutions, 2007. Look-Alike Sound-Alike Medication Names. Patient Safety Solutions, vol. 1. Solution 1, May 2007.

